Indications
Osteoinductive agent for use in the treatment of long-bone fractures as an adjunct to standard surgical care using open fracture reduction in dogs.
Composition
- Active substance
- dibotermin alfa
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- TruScient
- Active substance
- dibotermin alfa
- Group
- Veterinary medicines
- Marketing authorisation holder
- Zoetis Belgium SA
- Status
- Withdrawn
- EU authorisation
- 14 Dec 2011
- EMA product number
- EMEA/V/C/002000